Table 1.
N (%) of Treated Subjects |
|||
---|---|---|---|
All (36 subjects) | On-demand (19 subjects) | Prophylaxis (17 subjects) | |
Age | |||
≥7 and <12 years | 5 (13.9) | 2 (10.5) | 3 (17.6) |
≥12 and <16 years | 4 (11.1) | 2 (10.5) | 2 (11.8) |
≥16 years of age | 27 (75.0) | 15 (78.9) | 12 (70.6) |
Race | |||
White | 29 (80.6) | 14 (73.7) | 15 (88.2) |
Asian | 3 (8.3) | 2 (10.5) | 1 (5.9) |
Black or African American | 2 (5.6) | 2 (10.5) | 0 (0.0) |
Other | 2 (5.6) | 1 (5.3) | 1 (5.9) |
Ethnicity | |||
Non-hispanic or non-latino | 32 (88.9) | 17 (89.5) | 15 (88.2) |
Hispanic or Latino | 4 (11.1) | 2 (10.5) | 2 (11.8) |
Haemophilia type | |||
Haemophilia A | 33 (91.7) | 17 (89.5) | 16 (94.1) |
Haemophilia B | 3 (8.3) | 2 (10.5) | 1 (5.9) |
Severity of haemophilia | |||
Moderate | 3 (8.3) | 2 (10.5) | 1 (5.9) |
Severe | 33 (91.7) | 17 (89.5) | 16 (94.1) |
Number of target joints | |||
0 | 9 (25.0) | 5 (26.3) | 4 (23.5) |
1 | 14 (38.9) | 8 (42.1) | 6 (35.3) |
2–3 | 8 (22.2) | 4 (21.1) | 4 (23.5) |
≥4 | 5 (13.9) | 2 (10.5) | 3 (17.6) |